Zihao Li

Harbin, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

RGS16 Aggravates Hepatic Ischemia-Reperfusion Injury via Hepatocyte-Intrinsic Apoptosis/Inflammation & Neutrophil Recruitment/NETosis.

RGS16 Aggravates Hepatic Ischemia-Reperfusion Injury via Hepatocyte-Intrinsic Apoptosis/Inflammation & Neutrophil Recruitment/NETosis.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 15, 2026

Cancer-Associated Fibroblasts Promote Tumor Immunosuppression in Hepatocellular Carcinoma via the NNMT-ANGPTL4 Axis.

Cancer-Associated Fibroblasts Promote Tumor Immunosuppression in Hepatocellular Carcinoma via the NNMT-ANGPTL4 Axis.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: October 27, 2025

NNMT/1-MNA protects against hepatic ischemia-reperfusion injury through the AKT/FOXO1/ANGPT2/JNK axis.

NNMT/1-MNA protects against hepatic ischemia-reperfusion injury through the AKT/FOXO1/ANGPT2/JNK axis.

Journal: Nature communications
Published: October 24, 2024

Axin formation inhibitor 1 aggravates hepatic ischemia‒reperfusion injury by promoting the ubiquitination and degradation of PPARβ.

Axin formation inhibitor 1 aggravates hepatic ischemia‒reperfusion injury by promoting the ubiquitination and degradation of PPARβ.

Journal: Nature communications
Published: August 27, 2024

GRINA alleviates hepatic ischemia‒reperfusion injury-induced apoptosis and ER-phagy by enhancing HRD1-mediated ATF6 ubiquitination.

GRINA alleviates hepatic ischemia‒reperfusion injury-induced apoptosis and ER-phagy by enhancing HRD1-mediated ATF6 ubiquitination.

Journal: Journal of hepatology
Published: July 23, 2024

Von Hippel-Lindau deficiency protects the liver against ischemia/reperfusion injury through the regulation of hypoxia-inducible factor 1α and 2α.

Von Hippel-Lindau deficiency protects the liver against ischemia/reperfusion injury through the regulation of hypoxia-inducible factor 1α and 2α.

Journal: Hepatology communications
Published: July 12, 2024

An integrative pan-cancer analysis of MASP1 and the potential clinical implications for the tumor immune microenvironment.

An integrative pan-cancer analysis of MASP1 and the potential clinical implications for the tumor immune microenvironment.

Journal: International journal of biological macromolecules
Published: June 12, 2024

Identification and validation of ferroptosis-related hub genes and immune infiltration in liver ischemia-reperfusion injury.

Identification and validation of ferroptosis-related hub genes and immune infiltration in liver ischemia-reperfusion injury.

Journal: Genomics
Published: March 14, 2024

RGS19 activates the MYH9/β-catenin/c-Myc positive feedback loop in hepatocellular carcinoma.

RGS19 activates the MYH9/β-catenin/c-Myc positive feedback loop in hepatocellular carcinoma.

Journal: Experimental & molecular medicine
Published: September 07, 2023

IRG1 restrains M2 macrophage polarization and suppresses intrahepatic cholangiocarcinoma progression via the CCL18/STAT3 pathway.

IRG1 restrains M2 macrophage polarization and suppresses intrahepatic cholangiocarcinoma progression via the CCL18/STAT3 pathway.

Journal: Cancer science
Published: August 24, 2023

TMEM147 aggravates the progression of HCC by modulating cholesterol homeostasis, suppressing ferroptosis, and promoting the M2 polarization of tumor-associated macrophages.

TMEM147 aggravates the progression of HCC by modulating cholesterol homeostasis, suppressing ferroptosis, and promoting the M2 polarization of tumor-associated macrophages.

Journal: Journal of experimental & clinical cancer research : CR
Published: June 22, 2023

RNF125 attenuates hepatocellular carcinoma progression by downregulating SRSF1-ERK pathway.

RNF125 attenuates hepatocellular carcinoma progression by downregulating SRSF1-ERK pathway.

Journal: Oncogene
Published: November 01, 2022
Showing 1-12 of 20

Last Updated: 09/26/2026